NM_018029.4:c.167A>G

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_018029.4(EBLN2):​c.167A>G​(p.Gln56Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000325 in 1,445,826 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)
Exomes 𝑓: 0.000033 ( 0 hom. )

Consequence

EBLN2
NM_018029.4 missense

Scores

2
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.342

Publications

2 publications found
Variant links:
Genes affected
EBLN2 (HGNC:25493): (endogenous Bornavirus like nucleoprotein 2)
PPP4R2 (HGNC:18296): (protein phosphatase 4 regulatory subunit 2) The protein encoded by this gene is a regulatory subunit of the serine/threonine-protein phosphatase 4 complex. In addition to being required for efficient DNA double strand break repair, this complex plays a role in organization of microtubules at centrosomes and processing of spliceosomal snRNPs. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2015]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.0875501).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
EBLN2NM_018029.4 linkc.167A>G p.Gln56Arg missense_variant Exon 1 of 1 ENST00000533473.1 NP_060499.3 Q6P2I7
PPP4R2NM_174907.4 linkc.419+1188A>G intron_variant Intron 5 of 8 ENST00000356692.10 NP_777567.1 Q9NY27-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
EBLN2ENST00000533473.1 linkc.167A>G p.Gln56Arg missense_variant Exon 1 of 1 6 NM_018029.4 ENSP00000432104.1 Q6P2I7
PPP4R2ENST00000356692.10 linkc.419+1188A>G intron_variant Intron 5 of 8 1 NM_174907.4 ENSP00000349124.5 Q9NY27-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD2 exomes
AF:
0.00000436
AC:
1
AN:
229530
AF XY:
0.00000802
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000937
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000325
AC:
47
AN:
1445826
Hom.:
0
Cov.:
62
AF XY:
0.0000362
AC XY:
26
AN XY:
719048
show subpopulations
African (AFR)
AF:
0.0000310
AC:
1
AN:
32236
American (AMR)
AF:
0.00
AC:
0
AN:
39080
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25540
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39594
South Asian (SAS)
AF:
0.00
AC:
0
AN:
83080
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53176
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5716
European-Non Finnish (NFE)
AF:
0.0000415
AC:
46
AN:
1107674
Other (OTH)
AF:
0.00
AC:
0
AN:
59730
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.446
Heterozygous variant carriers
0
3
6
8
11
14
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.0000413
Hom.:
0
Bravo
AF:
0.0000151

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Oct 30, 2023
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.167A>G (p.Q56R) alteration is located in exon 1 (coding exon 1) of the EBLN2 gene. This alteration results from a A to G substitution at nucleotide position 167, causing the glutamine (Q) at amino acid position 56 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.23
T
BayesDel_noAF
Benign
-0.57
CADD
Benign
1.4
DANN
Benign
0.94
DEOGEN2
Benign
0.0041
T
Eigen
Benign
-0.89
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.019
N
LIST_S2
Benign
0.19
T
M_CAP
Benign
0.0024
T
MetaRNN
Benign
0.088
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.0
N
PhyloP100
0.34
PrimateAI
Benign
0.43
T
PROVEAN
Benign
-0.72
N
REVEL
Benign
0.019
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0
D
Polyphen
0.66
P
Vest4
0.063
MutPred
0.36
Gain of glycosylation at S55 (P = 0.0054);
MVP
0.099
MPC
0.0049
ClinPred
0.12
T
GERP RS
0.21
Varity_R
0.22
gMVP
0.0037
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs375687114; hg19: chr3-73111399; API